Skip directly to content

Prevenar 13® (pneumococcal polysaccharide conjugate vaccine)

What is Prevenar 13® (Pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed) and what is it used for?

Prevenar 13 is a conjugate vaccine that helps provide protection against 13 serotypes of the bacterium, Streptococcus pneumoniae; a bacterium responsible for causing infection which can be grouped into categories of invasive and non invasive disease. Invasive disease includes both meningitis (infection of the membranes around the brain and spinal cord) or bacteraemia (blood infection). Non invasive disease is when the bacterium causes pneumonia (an infection of the lungs) or otitis media (infection of the middle ear).

Prevenar 13 may be given to adults, adolescents and infants over the age of 6 weeks.

Prevenar 13 will only protect against the 13 serotypes contained within the vaccine. As with all vaccines, Prevenar 13 may not protect everyone who is fully vaccinated.

When should the vaccine be administered?

Prevenar 13 is indicated for active immunisation of individuals from the age of 6 weeks and should be used in accordance with official available recommendations.

The medicine can only be obtained with a prescription.

Reference information
  • The European Medicines Agency (EMA) is a decentralised agency of the European Union (EU), located in Amsterdam, the Netherlands. The Agency is responsible for the scientific evaluation, supervision and safety monitoring of medicines developed by pharmaceutical companies for use in the EU. See what guidance they offer about Prevenar 13.
  • If you would like to see the Patient Information Leaflet or Summary of Product Characteristics for Prevenar 13 these can be found at the electronic Medicines Compendium (eMC).
PP-VAC-GBR-1377 / Oct 2019

Pfizer is unable to provide advice on personal medical matters. Please consult your doctor or other relevant health professionals for specific, health-related advice and support.

If you get any side effects when taking this or any other medicine, talk to your doctor or other relevant health professional e.g. pharmacist, nurse.. This includes any possible side effects not listed in the packaging leaflet. You can also report side effects directly via the Yellow Card Scheme at By reporting side effects, you can help provide more information on the safety of this medicine.